Medindia LOGIN REGISTER
Medindia

Anti-Diabetes Drug Lowers the Risk of Heart Failure

Canagliflozin is an anti-diabetes drug belongs to the gliflozin class or sodium-glucose transport subtype two inhibitors. Canagliflozin is administered either as a monotherapy or with metformin, sulfonylurea drugs, pioglitazone or insulin to achieve adequate glycemic control while treating diabetes patients.

Advertisement
Advertisement
Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional